Zentis Drugs Private Limited - Company Profile

Q: Who are the current directors of Zentis Drugs Private Limited?

The current directors of Zentis Drugs Private Limited are Neelam Nirankari, Sanchit Sidana, Surinder Pal Singh.

It is a pharma private limited company based in Ambala Cantt, Haryana, India, established in 2010.

2010 Ambala Cantt, Haryana, India Active

Last Updated: February 06, 2026

About Zentis Drugs Private Limited

Zentis Drugs Private Limited, a active private limited company, was established on 29 March 2010 in Ambala Cantt, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100HR2010PTC040302. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Neelam Nirankari (Director), Sanchit Sidana (Director), Surinder Pal Singh (Director). Past directors included Sanjay Kumar Sinha, Jagjit Singh, Vikas Sharma. It holds ₹2.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Kuldeep Nagar Nanhera Road, Ambala Cantt, Haryana, 133001.

Company Details

CIN/LLPIN
U24100HR2010PTC040302
Registration Number
040302
Incorporation Date
29 March 2010
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.50 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 06-02-2026
Paid Up Capital ₹ 0.50 M as on 06-02-2026
Company Age 15 Year, 11 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 2.60 M as on 06-02-2026
Revenue Growth **** -25.48% (FY 2023)
Profit Growth **** -377.23% (FY 2023)
Ebitda **** -19.37% (FY 2023)
Net Worth -21.47% (FY 2023)
Total Assets -3.06% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Zentis Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Zentis Drugs Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Neelam Nirankari	Director	04 Jan 2014	Current
Sanchit Sidana	Director	11 Nov 2016	Current
Surinder Pal Singh	Director	04 Jun 2011	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	04 Jun 2011	Past
Pramod Abcsdd	Director	04 Apr 2010	Past
Pramod Abcsdd	Director	04 Jun 2011	Past
Pramod Abcsdd	Additional Director	30 Sep 2014	Past
Pramod Abcsdd	Additional Director	29 Sep 2017	Past
Pramod Abcsdd	Director	06 Jan 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zentis Drugs.

Zentis Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.48% decrease. The company also saw a substantial fall in profitability, with a 377.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.47%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-25.48%

*******

Revenue from Operations

*******

-25.35%

*******

Total Assets

*******

-3.06%

*******

Profit or Loss

*******

-377.23%

*******

Net Worth

*******

-21.47%

*******

EBITDA

*******

-19.37%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zentis Drugs?

Unlock access to Zentis Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,600,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Icici Bank Limited : 0.26 Cr

Latest Charge Details

Date	Lender	Amount	Status
24 Jun 2014	Icici Bank Limited	₹2.60 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Zentis Drugs?

Unlock and access historical data on people associated with Zentis Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Zentis Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zentis Drugs's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zentis Drugs

Recent Activity within the Organization

Annual General Meeting

The activity Zentis Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Balance Sheet

Zentis Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
31 Mar 2025
Director Appointment

The activity Sanchit Sidana was appointed as a Director was appointed as a Director on 11 Nov 2016 & has been associated with this company since 9 years 3 months . was completed.
11 Nov 2016
Charges

Progress on A charge with Icici Bank Limited of Rs. 2.60 M registered on 24 Jun 2014 with Charge ID 10519135 was modified on 16 Jun 2015. was documented.
16 Jun 2015
Charges

A charge with Icici Bank Limited amounted to Rs. 2.60 M with Charge ID 10519135 was registered on 24 Jun 2014. was recorded as a recent event.
24 Jun 2014
Director Appointment

Neelam Nirankari was appointed as a Director was appointed as a Director on 04 Jan 2014 & has been associated with this company since 12 years 2 months . was recorded as a recent event.
04 Jan 2014

Explore recent activity and updates - View Recent Activity